Progress in Prevention
Baylor recognizes faculty excellence in research with DeBakey Awards - June 25, 2025
New Study Provides Comprehensive Insights into Rare Triglyceride Disorder - March 28, 2025
Transforming the recognition and management of persistent chylomicronemia - March 28, 2025
Lifestyle and your blood pressure - Feb 3, 2025
Understanding the Link Between Vital Exhaustion and Heart Health - Nov 21, 2024
Cardiovascular disease and smoking: efforts should be continued to reduce smoking prevalence - Jul 12, 2024
Keep it steady: the importance of maintaining healthy blood pressure - Feb 6, 2024
Modifiable risk factors responsible for half of cardiovascular diseases - Aug 28, 2023
Reduced levels of FKBP5 promote atrial fibrillation - Jul 6, 2023
Clinical trial finds that oral drug MK-0616 substantially reduces ‘bad’ cholesterol - March 14, 2023
Study: cholesterol substantially reduced with oral PCSK9 inhibitor - March 6, 2023
Findings support repurposing rheumatoid arthritis drug auranofin for diabetes - Oct 18, 2022
The good, the bad and the ugly of heart disease risk factors - Feb 24, 2022
Platelets mediate a beneficial allergic response that protects against yeast asthma - Sep 14, 2021
Lifestyle intervention, non-statin therapies in patients with elevated triglycerides recommended - Jul 28, 2021
From the labs to bedside: Genomics can drive precision medicine - March 17, 2020
Blood proteins help predict risk of developing heart failure - May 21, 2019
